Investigations on the metabolic pathways of cyclosporine: I. Excretion of cyclosporine and its metabolites in human bile—isolation of 12 new cyclosporine metabolites

References

• Aoyama T., Yamano S., Waxman D. J., Lapenson D. P., Meyer U. A., Fischer V., Tyndale R., Inaba T., Kalow W., Gelboin H. V., Gonzalez F. J. CytochromeP-450HPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. Journal of Biological Chemistry 1989; 264: 10388–10395
   PubMed Web of Science ®Google Scholar
• Bleck J. S., Schlitt H. J., Christians U., Schottmann R., Thiesemann C., Strohmeyer S., Kohlhaw K., Wonigeit K., Pichlmayr R., Sewing K. F. Ciclosporin metabolite pattern in blood and urine of kidney grafted patients in relation to liver function. European Journal of Clinical Pharmacology 1991, In press
   Google Scholar
• Bowers L. D. Studies of cyclosporine metabolite toxicity in renal and hepatocyte culture systems. Transplantation Proceedings 1990; 22(3)1135–1136
   PubMedGoogle Scholar
• Bowers L. D., Norman D. D., Henion J. D. Isolation and characterization of cyclosporine metabolites using HPLC and tandem mass spectrometry. Transplantation Proceedings 1988; 20: 597–601
   PubMedGoogle Scholar
• Christians U., Schlitt H. J., Bleck J. S., Kownatzki R., Schiebel H. M., Maurer G., Strohmeyer S. S., Schottmann R., Wonigeit K., Pichlmayr R., Sewing K. F. Measurement of cyclosporine and 18 metabolites in blood, bile and urine by high performance liquid chromatography (HPLC). Transplantation Proceedings 1988a; 20: 609–613
   PubMedGoogle Scholar
• Christians U., Zimmer K. O., Wonigeit K., Maurer G., Sewing K. F. Liquid chromatographic measurement of cyclosporin A and its metabolites in blood, bile and urine. Clinical Chemistry 1988b; 34: 34–39
   PubMedGoogle Scholar
• Christians U., Zimmer K. O., Wonigeit K., Sewing K. F. Measurement of cyclosporin A and four of its metabolites in whole blood by high-performance liquid chromatography. Journal of Chromatography 1987; 413: 121–129
   PubMed Web of Science ®Google Scholar
• Christians U., Sewing K. F. Whole blood sample clean-up for chromatographic analysis. Selective Sample Handling and Detection in High-performance Liquid Chromatography, K. Zech, R. W. Frei. Elsevier, Amsterdam 1989; 82–132, part B
   Google Scholar
• Combalbert J., Fabre I., Fabre G., Dalet I., Derancourt J., Cano J. P., Maurel P. Metabolism of cyclosporin A: IV. Purification and identification pf the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug and Disposition 1989; 17: 197–207
   PubMed Web of Science ®Google Scholar
• Consensus Document. Hawk's Cay meeting on the therapeutic drug monitoring of cyclosporine. Transplantation Proceedings 1990; 22(3)1357–1361
   PubMedGoogle Scholar
• Copeland K. R., Yatscoff R. W., McKenna R. M. Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance. Clinical Chemistry 1990; 36: 225–229
   PubMedGoogle Scholar
• Davenport A., Will E. J., Davison A. M., Ironside J. W. Toxicity of cyclosporine metabolites. Lancet 1988; 2: 333
   PubMedGoogle Scholar
• Donatsch P., Rickenberger U., Brouillard J. F. Sandimmun metabolites: their potential to cause adverse reactions in the rat. Transplantation Proceedings 1990; 22(3)1137–1140
   PubMedGoogle Scholar
• Hartmann N. R., Jardine I. Mass spectrometric analysis of cyclosporine metabolites. Biomedical and Environmental Mass Spectrometry 1986; 13: 361–372
   Google Scholar
• Hartmann N. R., Jardine I. The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen cyclosporine metabolites. Drug Metabolism and Disposition 1987; 15: 661–664
   PubMedGoogle Scholar
• Hartmann N. R., Trimble L. A., Vegeras J. C., Jardine I. An acid metabolite of cyclosporine. Biochemical and Biophysical Research Communications 1985; 133: 964–971
   PubMedGoogle Scholar
• Hashem H., Venkataramanan R., Burckart G. J., Makowka L., Starzl T. E., Fu E., Wong L. K. Identification of the aldehydic metabolites. Transplantation Proceedings 1988; 20: 176–178
   PubMedGoogle Scholar
• Henricsson S., Lindholm A., Johansson A. Identification of a sulfate conjugate of cyclosporine. Transplantation Proceedings 1989; 21: 837–839
   PubMedGoogle Scholar
• Kessler H., Loosli H. R., Oschkinat H. Assignment of the 1H, 13C, and 15N-NMR spectra of cyclosporin A in CDCl3 and C6D6 by a combination of homo- and heteronuclear two dimension techniques. Helvetica Chimica Acta 1986; 99: 841–845
   Google Scholar
• Kohlhaw K., Wonigeit K., Schäfer O., Ringe B., Bunzendahl H., Pichlmayr R. Association of very high blood levels of cyclosporine metabolites with clinical complications after liver transplantations. Transplantation Proceedings 1989; 21: 2232–2233
   PubMedGoogle Scholar
• Kronbach T., Fischer V., Meyer U. A. Cyclosporine metabolism in human liver: identification of a cytochrome P450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clinical Pharmacology and Therapeutics 1988; 43: 630–635
   PubMed Web of Science ®Google Scholar
• Kunzendorf U., Brockmüller J., Joachimsen F., Keller P., Walz G., Offermann G. Cyclosporin metabolites and central-nervous-systern toxicity. Lancet 1988; 1: 1223
   PubMedGoogle Scholar
• Leunissen K., Baumann G., Bosman R., Van Hoof J. P. Cyclosporin metabolites and nephrotoxicity. Lancet 1986; 2: 1398
   PubMed Web of Science ®Google Scholar
• Lucey M. R., Kolars J. C., Merion R. M., Campbell D. A., Aldrich M., Watkins P. B. Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA. Lancet 1990; 335: 11–15
   PubMed Web of Science ®Google Scholar
• Maurer G. Metabolism of cyclosporine. Transplantation Proceedings 1985; 17: 19–26
   PubMed Web of Science ®Google Scholar
• Maurer G., Lemaire M. Biotransformation of cyclosporine and distribution in blood. Transplantation Proceedings 1986; 18: 25–34
   PubMed Web of Science ®Google Scholar
• Maurer G., Loosli R., Schreier E., Keller H. Disposition of cyclosporine in several animal species and man—structural elucidation of its metabolites. Drug Metabolism and Disposition 1984; 12: 120–126
   PubMed Web of Science ®Google Scholar
• Petcher T. J., Weber H. P., Rüegger A. Structure of an iodo-derivate of the cyclic undecapeptide cyclosporin A. Helvetica Chimica Acta 1976; 59: 1480–1488
   PubMed Web of Science ®Google Scholar
• Roesel T., Le Grue S. J., Liehr J., Kahan B. D. Isolation and in vitro characterization of a novel immunosuppressive cyclosporine metabolite. Transplantation 1989; 47: 149–156
   PubMedGoogle Scholar
• Rosano T. G., Pell M. A., Freed B. M., Dybas M. T., Lempert N. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioim-munoassay studies. Transplantation Proceedings 1988; 20: 330–338
   PubMedGoogle Scholar
• Rüegger A., Kuhn M., Lichti H. R., Hueguenin R., Quiquerez C., von Wartburg A. Cyclosporin A, ein immunsuppressiver Metabolit aus Trichoderma polysporum (Link ex Pers) Rifai. Helvetica Chimica Acta 1976; 59: 1075–1092
   PubMed Web of Science ®Google Scholar
• Ryffel B., Foxwell B. M. J., Mihatsch M. J., Donatsch P., Maurer G. Biological significance of cyclosporine metabolites. Transplantation Proceedings 1988; 20: 575–584
   PubMedGoogle Scholar
• Schlitt H. J., Christians U., Wonigeit K., Sewing K. F., Pichlmayr R. Immunosuppressive activity of cyclosporine metabolites in vitro. Transplantation Proceedings 1987; 19(5)4248–4251
   PubMedGoogle Scholar
• Sewing K. F., Christians U., Kohlhaw K., Radeke H., Strohmeyer S., Kownatzki R., Budniak J., Schottmann R., Bleck J. S., Almeida V. M. F., Deters M., Wonigeit K., Pichlmayr R. Biologic activity of cyclosporine metabolites. Transplantation Proceedings 1990; 22(3)1129–1134
   PubMedGoogle Scholar
• Wallemacq P. E., Lhoëst G., Latinne D., de Bruyere M. Isolation, characterization and in vitro activity of cyclosporin A metabolites. Transplantation Proceedings 1989a; 21: 906–910
   PubMedGoogle Scholar
• Wallemacq P. E., Lhoëst G., Dumont P. Isolation, purification and structure elucidation of cyclosporin A metabolites in rabbit and man. Biomedical and Environmental Mass Spectrometry 1989b; 18: 48–56
   PubMedGoogle Scholar
• Wang C. P., Hartmann N. R., Venkataramanan R., Jardine I., Lin F. T., Knapp J. E., Starzl T. E., Burckart G. J. Isolation of 10 cyclosporine metabolites from human bile. Drug Metabolism and Disposition 1989; 17: 292–296
   PubMedGoogle Scholar
• Wenger R. Pharmacology of cyclosporin (Sandimmune), II, Chemistry. Pharmacological Reviews 1989; 41: 243–247
   Google Scholar
• Wenger R. M. Structures of cyclosporine and its metabolites. Transplantation Proceedings 1990; 22(3)1104–1108
   PubMedGoogle Scholar
• Wonigeit K., Kohlhaw K., Winkler M., Schaefer O., Pichlmayr R. Cyclosporine monitoring in liver allograft recipients: two distinct patterns of blood level derangement associated with nephrotoxicity. Transplantation Proceedings 1990; 22(3)1305–1311
   PubMedGoogle Scholar